IP Library Granted Patent US 10,047,404
Granted Patent B2
US 10,047,404 · App. 14/515,371 · Granted Aug 14, 2018

Highly conserved tuf genes and their use to generate probes and primers for detection of coagulase-negative

Inventors: Michel G. Bergeron (Quebec, CA); Maurice Boissinot (Saint-Augustin-de-Desmaures, CA); Ann Huletsky (Sillery, CA); Christian Menard (St-Lambert-de-Levis, CA); Marc Ouellette (Sillery, CA); Francois J. Picard (Cap-Rouge, CA); Paul H. Roy (Loretteville, CA)
Assignee: GENEOHM SCIENCES CANADA, INC.
C12Q1/689C12Q1/14C12Q2600/156C12Q2600/16C12Q2600/166G01N2333/195G01N2333/31
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,047,404
App. No.
14/515,371
Granted
Aug 14, 2018
Kind
B2
Abstract

Provided herein are compositions and methods for the detection of Streptococcus agalacticae.

Claims (12)

1. A method for specifically detecting the presence or absence in a sample of a tuf nucleic acid sequence belonging to a coagulase negative Staphylococcus comprising:

i) contacting the sample with an oligonucleotide probe or primer that hybridizes to a tuf nucleic acid sequence of each of SEQ ID NOs: 181, 182, 184-188, and 190-202 at nucleotides corresponding to nucleotides 313-679 of SEQ ID NO: 179, or complements thereof, but does not hybridize to a tuf nucleic acid sequence of any of SEQ ID NOs: 176-180 under stringent hybridization conditions of 55° C., 1.5 M NaCl and 10 mM EDTA;

ii) allowing said oligonucleotide to hybridize with said sample under conditions such that said oligonucleotide hybridizes to a tuf nucleic acid sequence of any of SEQ ID NOs: 181, 182, 184-188, and 190-202 at nucleotides corresponding to nucleotides 313-679 of SEQ ID NO: 179, or complements thereof, if present, but does not hybridize to a tuf nucleic acid sequence of any of SEQ ID NOs: 176-180 if present; and

iii) testing for hybridization of said oligonucleotide to a tuf nucleic acid sequence of SEQ ID NOs: 181, 182, 184-188, and 190-202 or complements thereof in said sample.

2. The method of claim 1 , wherein the nucleic acid sequence of said oligonucleotide comprises SEQ ID NO: 1175 or 1176 or a complement thereof.

3. The method of claim 1 , further comprising amplifying said tuf nucleic acid prior to hybridization of said oligonucleotide to said tuf nucleic acid.

4. The method of claim 3 , wherein said tuf nucleic acid is amplified using a first primer comprising the nucleic acid sequence of SEQ ID NO: 553 and a second primer comprising a nucleic acid sequence of SEQ ID NO: 575 or 707.

5. The method of claim 3 , wherein said oligonucleotide is a probe comprising the nucleic acid sequence of SEQ ID NO: 1175 or 1176.

6. The method of claim 5 , wherein said oligonucleotide comprises the nucleic acid sequence of SEQ ID NO: 1233.

7. The method of claim 4 , wherein said oligonucleotide is a probe comprising the nucleic acid sequence of SEQ ID NO: 1175 or 1176.

8. The method of claim 7 , wherein said oligonucleotide comprises the nucleic acid sequence of SEQ ID NO: 1233.

9. The method of claim 1 , wherein the nucleic acid sequence of said oligonucleotide consists of SEQ ID NO: 1175 or 1176 or a complement thereof.

Priority Claims (2)
CA 2283458 · Sep 28, 1999 · national
CA 2307010 · May 19, 2000 · national
Continuity (6)
Continuation 13867986 · Apr 22, 2013
Continuation 13176626 · Jul 5, 2011
Continuation 11522253 · Sep 14, 2006
Continuation In Part 11236785 · Sep 27, 2005
Continuation 10089177
Related Publication 20150111760A1 · Apr 23, 2015
Cited By (2)
US 12,403,179 US 12,569,547